Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2007 Financial Results

Wednesday, March 26, 2008 General News J E 4
BEIJING, March 25 Sinovac Biotech Ltd. (Amex: SVA),a leading provider of vaccines in China, today announced that it will host aconference call on Monday, March 31, 2008 at 9:00 a.m. ET to review theCompany's fourth quarter and year ended December 31, 2007 financial resultsand provide an update on recent corporate developments.

To access the conference call, please dial 1-877-407-4018 (USA) or 1-201-689-8471 (international). A replay of the call will be available from 12:00p.m. ET on March 31, until April 14, 2008 at midnight. To access the replay,please dial 1-877-660-6853 (USA) or 1-201-612-7415 (international) andreference the account number 3055 and the access code 279686.

A live audio webcast of the call will also be available from the Investorssection on the corporate web site at . A webcast replaycan be accessed on the corporate website beginning March 31, 2008 and thereplay will remain available for 30 days.

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company thatfocuses on the research, development, manufacture and commercialization ofvaccines that protect against human infectious diseases. Sinovac's vaccinesinclude HealiveTM (hepatitis A), BiliveTM (combined hepatitis A and B) andAnfluTM (influenza). Sinovac is currently developing human vaccines againstthe H5N1 strain of pandemic influenza, Japanese encephalitis and SARS.Additional information about Sinovac is available on its website, . To be added to our distribution list, please more information, please contact: Contact Information: Helen G. Yang Sinovac Biotech Ltd. Tel: +86-10-8289-0088 Ext. 871 Fax: +86-10-6296-6910 Email: Investors / Media: Stephanie Carrington / Janine McCargo The Ruth Group Tel: 646-536-7017/7033 Email: /

SOURCE Sinovac Biotech Ltd.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
High-Performing Healthcare Organizations Have Seve...
WeissComm Partners Promotes Diane Weiser to Presid...